Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases

Abstract Central nervous system (CNS) metastases are associated with poor prognosis in patients with metastatic breast cancer (MBC). In this retrospective study, we investigated the activity of sacituzumab govitecan (SG) in 33 patients with HER2-negative MBC and CNS metastases, including active, sta...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Thomas Grinda, Stefania Morganti, Liangge Hsu, Tae-Kyung Yoo, Ross J. Kusmick, Ayal A. Aizer, Antonio Giordano, Jose P. Leone, Melissa Hughes, Sara M. Tolaney, Nancy U. Lin, Sarah L. Sammons
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Nature Portfolio 2025-03-01
Reeks:	npj Breast Cancer
Online toegang:	https://doi.org/10.1038/s41523-025-00736-9
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!